Latest News for: relapse
Edit
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Nasdaq Globe Newswire 24 Dec 2025
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis ... .
Edit
Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support
Nasdaq Globe Newswire 24 Dec 2025
Edit
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis (Sanofi SA)
Public Technologies 24 Dec 2025
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025 ... accumulation independent of relapse activity in adults.
Edit
The Eagle-Tribune
22 Dec 2025
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
Edit
FDA approves Roche’s Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma
Nasdaq Globe Newswire 22 Dec 2025
RHHBY) announced today that the US Food and Drug Administration (FDA) has approved CD20xCD3 bispecific Lunsumio VELO™ ...
Edit
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma
Pharmiweb 22 Dec 2025
today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL).
Edit
Incyte Announces European Commission Approval of Minjuvi� (tafasitamab) for the Treatment of Relapsed or Refractory ...
Business Wire 18 Dec 2025
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Announces European Commission Approval of Minjuvi� (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma ... .
Edit
Cadillac News
17 Dec 2025
Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory ...
Edit
Claudine Barretto reveals relapse from anorexia, postpones big event with fans
The Philadelphia Inquirer 17 Dec 2025
Claudine Barretto shared that she had a relapse of anorexia, which was the reason she had to postpone a big event with ...
Edit
Man suffering from relapse of schizoaffective disorder found not guilty of murder by reason of insanity
The Irish Times 17 Dec 2025
Edit
Inside a Hollywood Tragedy: Nick Reiner’s Relapse and the Killings of Rob and Michele Reiner
The Wrap 16 Dec 2025
Edit
Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Nasdaq Globe Newswire 15 Dec 2025
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis ... .
Edit
News Graphic
15 Dec 2025
Some Can Slowly Taper Off Antidepressants Without Risk Of Relapse, Review Concludes
Key Takeaways ... .
Edit
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis (Form 6-K) (Sanofi SA)
Public Technologies 15 Dec 2025
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis • ... but continue to experience disability accumulation, in the absence of relapses.
Edit
Reduction In Antidepressant Use With Therapy Reduces Depression Relapse
NDTV 12 Dec 2025
Gradual reduction of antidepressants together with psychological support can be an effective strategy to stop medication among adults who have recovered from depression, according to a study on... .
- 1
- 2
- Next page »